Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Therapy areas
Others
Others
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Others
A New Therapy for Spinal Cord Injury
Firstwordpharma News
-
January 17, 2020
Others
Biocon plans to halve insulin prices ...
Others
Court to Look Anew at Health Care Law Birth Control Rules ...
Others
Do You Take Warfarin? Time of Day Might Not Matter ...
Others
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020
Others
UK, German cost-effectiveness bodies unconvinced by Bayer’s TRK inhibitor Vitrakvi
Firstwordpharma News
-
January 17, 2020
0
Others
BioSpace Movers & Shakers, Jan. 17
Biospace News
-
January 17, 2020
0
Others
Eli Lilly Plans Spending Spree for 2020
Biospace News
-
January 17, 2020
0
Others
J.P. Morgan Day 4: Moderna, Berkeley Lights, Sanofi, Pfizer and More
Biospace News
-
January 17, 2020
0
Others
Who are the 10 Most Innovative Biopharma Companies?
Biospace News
-
January 17, 2020
0
1
2
3
...
193
Page 1 of 193
- Advertisement -
MOST POPULAR
Prevail Therapeutics Announces FDA Orphan Drug Designation Granted to PR006 for...
December 16, 2019
Axovant Announces Positive 12-month Data on AXO-Lenti-PD and Provides Updates...
January 13, 2020
IDEAYA Biosciences Reports End?of?Phase 1 Meeting with FDA for IDE196 Confirms...
October 31, 2019
Louisiana picks drug company for hepatitis C treatment plan ...
March 26, 2019
Load more
HOT NEWS
Clinical
New FDA Drug Safety Communication on Uloric (febuxostat) – Drug Information...
Commercial
Ad hoc: MorphoSys Announces That Its Patents Were Ruled Invalid in...
Commercial
Tricida Announces $200 Million Debt Facility With Hercules Capital
Commercial
Iterum Therapeutics Reports Third Quarter 2019 Financial Results and Highlights
